Houston Methodist 13th Annual Houston Methodist Cancer Symposium 2025

• Target Audience: practicing oncologists, medical, surgical, and radiation oncologists
• Sample video: contact me for sample video
• Information:

This annual symposium, dedicated to the science and clinical care of solid and hematologic malignancies, brings together Houston Methodist scientists and physicians from a broad spectrum of fields, including basic, clinical, and epidemiological research. A wide range of topics will be covered, from innovative translational science to clinical updates with strategies for implementation in current clinical practice. The program will provide education focused on improving patient care, research collaboration and leading medicine.

Target Audience

Physician scientists, practicing oncologists, physician assistants, advanced nurse practitioners, oncology nurses, residents, fellows, medical students, allied health care professionals and clinical research associates will benefit from this course.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

Discuss the fundamental mechanisms of cellular immunotherapy in hematologic malignancies

Describe the approved cell therapy options in hematologic malignancies including CAR-T cell

Identify new cellular therapies in the pipeline for these diseases

The Houston Methodist 13th Annual Cancer Symposium (2025) is best for clinicians, researchers, and care teams seeking state-of-the-art updates spanning solid and hematologic malignancies, with a practical focus on translating innovations into current practice.

Who should attend

Medical, surgical, and radiation oncologists: Evidence-based updates and implementation strategies across tumor types

Pathologists and radiologists: Translational science that impacts diagnostics and treatment planning

Hematologists and bone marrow transplant teams: Advances in hematologic malignancies and supportive care

Nurses, pharmacists, and advanced practice providers: Multiprofessional perspectives and clinical takeaways for daily care

Researchers and trainees: Opportunities to present abstracts and engage with cutting-edge cancer science

What you’ll learn

Innovative translational science: From bench discoveries to bedside applications in oncology

Outcomes-focused practice: Content designed to enhance competency and real-world patient care

• Topics:

13th Annual Houston Methodist Cancer Symposium

August 15, 2025

Time

Presentation

Speaker

7:30 AM

Registration

8:20 AM

Welcome

8:30 AM

Oncology Keynote: Developing Innovative Therapy

Lawrence Einhorn, MD

9:15 AM

Question and Answer Session

9:25 AM

Renal Cell Carcinoma State of Research: Accomplishments and Future Directions

Nizar Tannir, MD, FACP

9:55 AM

Question and Answer Session

10:00 AM

Break and Exhibits

10:25 AM

Advances in the Management of Metastatic Castration Sensitive Prostate Cancer: What the Future Holds

Jorge Garcia, MD, MSc, FACP

10:55 AM

Question and Answer Session

11:00 AM

Sadeer Al – Kindi, MD, FACC

11:30 AM

Question and Answer Session

11:35 AM

Lunch Keynote I: CAR T Therapy: Milestones in Cancer Immunotherapy and New Horizons in Targeting PSMA

Bin He, PhD

12:05 PM

Lunch Keynote II: Trauma Informed Care in Oncology

Jessica Blanc, MSW, LCSW

12:35 PM

Lunch and Exhibits

1:00 PM

AI foundation models in the front of biomedicine

Guangyu Wang, PhD

1:45 PM

Question and Answer Session

1:55 PM

AI in Healthcare: Enhancing Diagnosis and Decision-Making

2:25 PM

Question and Answer Session

2:30 PM

Break and Exhibits

2:45 PM

Current and Future Technologies and Artificial Itelligence in Diagnostic Hematopathology

John Rogers, MD

3:15 PM

Question and Answer Session

3:20 PM

Break and Exhibits

3:50 PM

Abstract Winner Discussions

4:30 PM

Question and Answer Session

4:45 PM

Adjournment